Seeking more efficient drug development, pharmaceutical giants and startups are encouraging AI fluency and in some cases ...

Eli Lilly plans to globally launch its diabetes and weight-loss drug, Mounjaro, in countries including China, India, Brazil, ...

Eli Lilly plans to release its diabetes and weight-loss drug, Mounjaro, in major global markets like China, India, Brazil, ...

Parnassus Core Equity Fund sees Eli Lilly And Co. (NYSE:LLY) as a strong long-term investment due to its GLP-1 franchise and ...

Jim Cramer recently talked about the market selloff and how years of profits are lost within days when panic hits the market: ...

Stock splits tend to create a lot of buzz in the market, especially when some of the most prominent companies announce a ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

MAPsignals data shows how Big Money investors are betting heavily on the forward picture of the stock. Plenty of health care ...

In addition to Novo Nordisk (which provides Ozempic), Eli Lilly and its Mounjaro weight-loss drug have ... your chance to see life-changing profits from AI isn’t over. The 24/7 Wall Street ...

Whoopi Goldberg says she used to weight 300 pounds before turning to Mounjaro, a weight loss drug. Before then, she says she ...